| scholarly article | Q13442814 |
| P50 | author | Heiner Grosskurth | Q39062919 |
| P2093 | author name string | Andrew Nunn | |
| Jonathan Levin | |||
| Paula Munderi | |||
| Andrew Abaasa | |||
| Zacchaeus Anywaine | |||
| Ronnie Kasirye | |||
| Joseph Kayiira Lutaakome | |||
| P2860 | cites work | Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda. | Q52855669 |
| Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi | Q62487042 | ||
| Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review | Q21133667 | ||
| Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design | Q24569560 | ||
| Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial | Q28552031 | ||
| Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe | Q28730357 | ||
| Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire | Q33368355 | ||
| Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial | Q33587553 | ||
| Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa | Q34209707 | ||
| Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990-2013. | Q35684087 | ||
| Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design | Q35973095 | ||
| Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study | Q36517673 | ||
| Global Policy Review of Recommendations on Cotrimoxazole Prophylaxis among People Living with HIV. | Q38217764 | ||
| Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis | Q38596372 | ||
| HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea | Q38868223 | ||
| Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort | Q38872771 | ||
| Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda | Q38879309 | ||
| The pros and cons of noninferiority trials | Q39361105 | ||
| Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine | Q43758891 | ||
| Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group | Q43836224 | ||
| Skin reactions to co-trimoxazole | Q44368559 | ||
| Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? | Q47877517 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Uganda | Q1036 |
| placebo | Q269829 | ||
| P304 | page(s) | e0206907 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial | |
| P478 | volume | 13 |
Search more.